Description

Lecture will aim to provide the current evidence regarding the efficacy and safety of autologous PRP therapy in treating lumbar spine disorders. It will examine the biologic rationale for the use of PRP to treat common lumbar spine conditions, such as degenerative disc disease, facet joint arthropathy, and lumbar radiculopathy. The lecture will present latest and key clinical studies, with a focus on randomized controlled trials to evaluate the effectiveness of PRP injections in alleviating low back pain and improving functional outcomes.  

Key topics will include 1. RCTs on PRP to the disc, facet and epidural space 2. Discussion of the functional spine unit approach and current evidence for its use 3. Clinical decision making in the use of PRP for lumbar spine. The lecture will also address potential adverse effects associated with PRP therapy and discuss the limitations of current research, highlighting areas where further investigation is needed. By the end of the session, attendees should be equipped to make informed, evidence-based decisions regarding the integration of PRP therapy into clinical practice for managing lumbar spine conditions. 

Learning Objectives

• Learning Objective 1: Understand the rationale and pathophysiology for the use of biologics for low back pain
• Learning Objective 2: Acquire a knowledge of the key RCTs on the use of PRP for lumbar spine conditions
• Learning Objective 3: Comprehend the functional spine unit approach in using Biologics for Low back pain
• Learning Objective 4: Learn how to make informed clinical decision making in the use of PRP for Chronic LBP

Member Community
Regenerative Medicine

Accreditation Statement
The American Academy of Physical Medicine and Rehabilitation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation of Credit
The American Academy of Physical Medicine and Rehabilitation (AAPM&R) designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.  

Financial Disclosures
AAPM&R requires all individuals who are in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest, which is any entity producing, marketing, re-selling or distributing health care goods or services consumed by, or used on, patients. Disclosures are made in written form prior to the start of the educational activity and any potential conflicts of interest that exist are resolved prior to the start of the activity through AAPM&R’s Conflict of Interest Disclosure and Resolution Policy Process. Individuals in a position to control content and their disclosed financial relationships are listed below.

Faculty
Session Director: Mary Ambach, MD, FAAPMR: Disclosed no relevant financial relationships.    

AAPM&R Medical Education Committee
John C. Cianca, MD: Ownership or partnership with Musculoskeletal Ultrasound Consultants, LLC.
Karen P. Barr, MD: Disclosed no relevant financial relationships.
Rachel A. Brakke Holman, MD: Disclosed no relevant financial relationships.
Joseph E. Burris, MD: Serves on the Speakers Bureau for, and received clinical research grants from Allergan.
David S. Cheng, MD: Disclosed no relevant financial relationships.
Theresa A. Gillis, MD: Disclosed no relevant financial relationships.
Kevin N. Hakimi, MD: Disclosed no relevant financial relationships.
Matthew T. Haas, MD: Disclosed no relevant financial relationships.
R.Samuel Mayer, MD: Royalties from Demos Medical Publishing.
Ameet S. Nagpal, MD MS MEd: Disclosed no relevant financial relationships.
Sunil Sabharwal, MD: Royalities from Demos Publishing; board member, American Board of Physical Medicine and Rehabilitation.
Sarah M. Smith, MD: Disclosed no relevant financial relationships.
Stephanie Tow, MD: Disclosed no relevant financial relationships.
Kevin R. VIncent, MD, PhD: Disclosed no relevant financial relationships.

AAPM&R CME Committee
Karen P. Barr, MD: Disclosed no relevant financial relationships.
Cherry C. Junn, MD: Disclosed no relevant financial relationships.
Sheryl R. Levin, MD: Disclosed no relevant financial relationships.
Kentaro Onishi, DO: Disclosed no relevant financial relationships.
Evan R. Peck, MD: Disclosed no relevant financial relationships.
Cynthia G. Pineda, MD: Disclosed no relevant financial relationships.
Patricia T. Tan, MD: Disclosed no relevant financial relationships.
Brionn K. Tonkin, MD: Disclosed no relevant financial relationships.
Kristin A. Wong, MD: Disclosed no relevant financial relationships.

No other planners, faculty or other individuals in control of content disclosed any relevant financial relationships.

FDA Disclosures
All faculty members for this activity have disclosed they do not intend to discuss or demonstrate any pharmaceutical or medical device for which FDA clearance has not been approved.